xenome Pages on BioPortfolio:

BioPortfolio - xenome
BioPortfolio - Xenome Ltd - Entry on Bioportfolio's Biocorporate Database. ... View the current Xenome Limited Page on BioPortfolio.com . ...
http://www.bioportfolio.com/search/xenome.html...

BioPortfolio - Xenome Limited - Profile
View the current Xenome Limited Page on BioPortfolio.com ... Xenome aims to develop new treatments for pain, particularly intractable pain as experienced by
...
http://www.bioportfolio.com/biocorporate/11089-Xenome+Limite...

BioPortfolio - Xenome Ltd Queensland
Xenome Ltd Queensland - BioPortfolio. ... Xenome Ltd Strengthens Management Team And Launches US Presence ... Previously Kathryn was founding Chief . ...
http://www.bioportfolio.com/search/Xenome_Ltd_Queensland.htm...

BioPortfolio - xenome 2008
xenome 2008 - BioPortfolio. ... Recent Search Terms used to find this page: xenome 2008 | xenome biopharma ... Leading Bioscience Fund GBS Invests $6 ...
http://www.bioportfolio.com/search/xenome_2008.html...

BioPortfolio - XENOME LIMITED
XENOME LIMITED - BioPortfolio. ... Xenome Limited - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/XENOME_LIMITED.html...

BioPortfolio - xenome ltd
xenome ltd - BioPortfolio. ... Xenome Limited - Entry on Bioportfolio's Biocorporate Database. http://www.bioportfolio.com/biocorporate/11089-
Xenome_Limite. ...
http://www.bioportfolio.com/search/xenome_ltd.html...

...

BioPortfolio - xenome australia
xenome australia - BioPortfolio. ... Xenome Ltd. was established to mine the diverse therapeutic potential of Australia's terrestrial and marine biota, ...
http://www.bioportfolio.com/search/xenome___australia.html...

Results from other life science and pharmaceutical sites:

Media Release XENOME’S PAIN DRUG XEN2174 ENTERS HUMAN CLINICAL ...
Xenome Limited last month gained Investigatory New Drug approval by the US Federal ... Xenome Limited, announced today that a Phase I clinical trial had
...
http://www.cytopia.com.au/pdf/2004/07-20-04%20-%20Announceme...

Xenome Ltd Launches MultiCentre Clinical Trial For Severe Cancer ...
15 /PRNewswire/ -- Xenome Limited today announced it had commenced a Phase I/IIa trial of Xen2174, a new class of peptide therapeutic for the treatment of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2694...

Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
5 /PRNewswire/ -- Xenome Limited today announced the appointment of Ian Nisbet, PhD as the Company's Chief Executive Officer. Dr. Nisbet will also join ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Xenome Ltd Presents Xen2174 Data on Relief of Pain in Cancer ...
21 Aug 2008 ... A new drug for the treatment of severe pain under development by Australian biotechnology company Xenome Limited (“Xenome”) has shown ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107530...

Leading Bioscience Fund GBS Invests $6 Million in Xenome L ...
Brisbane, Australia, 23 July 2008: Biopharmaceutical company Xenome Limited (“ Xenome”) today announced it has received a convertible note placement of US$6
...
http://www.biospace.com/news_story.aspx?NewsEntityId=104199...

22 May 2003 Company Announcements Office Australian Stock Exchange ...
Please find herewith an announcement “Medica investee Xenome granted European ... Australian drug discovery company Xenome has been granted patent rights in
...
http://www.cytopia.com.au/pdf/2003/05-22-03%20-%20Announceme...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.